These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 29934015)

  • 1. Oxidized LDL and anti-oxidized LDL antibodies in atherosclerosis - Novel insights and future directions in diagnosis and therapy.
    Hartley A; Haskard D; Khamis R
    Trends Cardiovasc Med; 2019 Jan; 29(1):22-26. PubMed ID: 29934015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination to modulate atherosclerosis.
    Kimura T; Tse K; Sette A; Ley K
    Autoimmunity; 2015 May; 48(3):152-60. PubMed ID: 25683179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing a Strategy for Interventional Molecular Imaging of Oxidized Low-Density Lipoprotein in Atherosclerosis.
    Pandey SS; Haskard DO; Khamis RY
    Mol Imaging; 2017; 16():1536012117723788. PubMed ID: 28877655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease.
    Gounopoulos P; Merki E; Hansen LF; Choi SH; Tsimikas S
    Minerva Cardioangiol; 2007 Dec; 55(6):821-37. PubMed ID: 18091649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pro-inflammatory effect of uraemia overrules the anti-atherogenic potential of immunization with oxidized LDL in apoE-/- mice.
    Pedersen TX; Binder CJ; Fredrikson GN; Nilsson J; Bro S; Nielsen LB
    Nephrol Dial Transplant; 2010 Aug; 25(8):2486-91. PubMed ID: 20164045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-invasive imaging of vulnerable plaques by molecular targeting of oxidized LDL with tagged oxidation-specific antibodies.
    Tsimikas S; Shaw PX
    J Cell Biochem Suppl; 2002; 39():138-46. PubMed ID: 12552613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The fine-tuning of anti-oxidized low-density lipoprotein antibodies in cardiovascular disease and thrombosis.
    Freire de Carvalho J; Sherer Y; Shoenfeld Y
    Thromb Haemost; 2007 Dec; 98(6):1157-9. PubMed ID: 18064307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of oral tolerance to oxidized low-density lipoprotein ameliorates atherosclerosis.
    van Puijvelde GH; Hauer AD; de Vos P; van den Heuvel R; van Herwijnen MJ; van der Zee R; van Eden W; van Berkel TJ; Kuiper J
    Circulation; 2006 Oct; 114(18):1968-76. PubMed ID: 17060383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of oxLDL uptake leads to decreased atherosclerosis in hematopoietic NPC1-deficient Ldlr
    Jeurissen MLJ; Walenbergh SMA; Houben T; Gijbels MJJ; Li J; Hendrikx T; Oligschlaeger Y; van Gorp PJ; Binder CJ; Donners MMPC; Shiri-Sverdlov R
    Atherosclerosis; 2016 Dec; 255():59-65. PubMed ID: 27816810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced oxidized LDL in T2D plaques is associated with a greater statin usage but not with future cardiovascular events.
    Singh P; Goncalves I; Tengryd C; Nitulescu M; Persson AF; To F; Bengtsson E; Volkov P; Orho-Melander M; Nilsson J; Edsfeldt A
    Cardiovasc Diabetol; 2020 Dec; 19(1):214. PubMed ID: 33317535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating oxidized low-density lipoprotein: a biomarker of atherosclerosis and cardiovascular risk?
    Verhoye E; Langlois MR;
    Clin Chem Lab Med; 2009; 47(2):128-37. PubMed ID: 19099526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative modification of low-density lipoprotein and immune regulation of atherosclerosis.
    Matsuura E; Kobayashi K; Tabuchi M; Lopez LR
    Prog Lipid Res; 2006 Nov; 45(6):466-86. PubMed ID: 16790279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Imaging of Atherothrombotic Diseases: Seeing Is Believing.
    Wang X; Peter K
    Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1029-1040. PubMed ID: 28450298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylcholine-targeting immunization reduces atherosclerosis.
    Caligiuri G; Khallou-Laschet J; Vandaele M; Gaston AT; Delignat S; Mandet C; Kohler HV; Kaveri SV; Nicoletti A
    J Am Coll Cardiol; 2007 Aug; 50(6):540-6. PubMed ID: 17678738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Advances in Fluorescent Angioscopy for Molecular Imaging of Human Atherosclerotic Coronary Plaque.
    Uchida Y
    J Atheroscler Thromb; 2017 Jun; 24(6):539-551. PubMed ID: 28381766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Oxidized Phosphatidylinositols Present in OxLDL and Human Atherosclerotic Plaque.
    Hasanally D; Edel A; Chaudhary R; Ravandi A
    Lipids; 2017 Jan; 52(1):11-26. PubMed ID: 27914034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frontiers in positron emission tomography imaging of the vulnerable atherosclerotic plaque.
    MacAskill MG; Newby DE; Tavares AAS
    Cardiovasc Res; 2019 Dec; 115(14):1952-1962. PubMed ID: 31233100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human pericoronary adipose tissue as storage and possible supply site for oxidized low-density lipoprotein and high-density lipoprotein in coronary artery.
    Uchida Y; Uchida Y; Shimoyama E; Hiruta N; Kishimoto T; Watanabe S
    J Cardiol; 2017 Jan; 69(1):236-244. PubMed ID: 27209423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial DAMPs and altered mitochondrial dynamics in OxLDL burden in atherosclerosis.
    Khwaja B; Thankam FG; Agrawal DK
    Mol Cell Biochem; 2021 Apr; 476(4):1915-1928. PubMed ID: 33492610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low level natural antibodies against phosphorylcholine: a novel risk marker and potential mechanism in atherosclerosis and cardiovascular disease.
    Frostegård J
    Clin Immunol; 2010 Jan; 134(1):47-54. PubMed ID: 19748321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.